Efficacy and Tolerability of BAF312 in Patients With Polymyositis
Clinical trial NCT01801917 · TERMINATED
Trial details
- NCT number
- NCT01801917
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-24
- Primary completion
- 2016-08-05
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.